After earnings plunge, BioNTech pins hopes on cancer drug launches

Go back to After earnings plunge, BioNTech pins hopes on cancer drug launches
(NASDAQ: BNTX) Delayed: 91.09 +0.90 (1.00%)
Previous Close $90.19    52 Week High
Open $90.39    52 Week Low
Day High $91.71    P/E N/A 
Day Low $90.14    EPS
Volume 146,422